ORGANIC ACIDS AS AGENTS TO DISSOLVE CALCIUM MINERALS IN PATHOLOGICAL CALCIFICATION AND USES THEREOF
In an embodiment of the present disclosure, there is provided a composition for dissolving calcium oxalate crystals thereby inhibiting/preventing further growth of crystals. In some embodiments, such a composition comprises at least one stereoisomer of hydroxycitrate, a derivative of the organic aci...
Saved in:
| Format | Patent |
|---|---|
| Language | English |
| Published |
27.03.2019
|
| Online Access | Get full text |
Cover
| Abstract | In an embodiment of the present disclosure, there is provided a composition for dissolving calcium oxalate crystals thereby inhibiting/preventing further growth of crystals. In some embodiments, such a composition comprises at least one stereoisomer of hydroxycitrate, a derivative of the organic acid citrate. Such a method comprises administering to the subject an effective amount of the aforementioned composition. In another embodiment, the present disclosure pertains to a method of treating kidney stone disorder. Such a method comprises administering to a subject in need thereof a therapeutically effective amount of the aforementioned composition. In yet another embodiment, the present disclosure relates to a method of treating calcium oxalate stone disease. In an embodiment, the method comprises administering to a subject in need thereof a therapeutically effective amount of the aforementioned composition. |
|---|---|
| AbstractList | In an embodiment of the present disclosure, there is provided a composition for dissolving calcium oxalate crystals thereby inhibiting/preventing further growth of crystals. In some embodiments, such a composition comprises at least one stereoisomer of hydroxycitrate, a derivative of the organic acid citrate. Such a method comprises administering to the subject an effective amount of the aforementioned composition. In another embodiment, the present disclosure pertains to a method of treating kidney stone disorder. Such a method comprises administering to a subject in need thereof a therapeutically effective amount of the aforementioned composition. In yet another embodiment, the present disclosure relates to a method of treating calcium oxalate stone disease. In an embodiment, the method comprises administering to a subject in need thereof a therapeutically effective amount of the aforementioned composition. |
| BookMark | eNqNjMsKgzAURLNoF339w111V2ixCF2GeNULMSkmupUgFgSJQuz_N9B-QGFgBs5h9mzjZz_sWK_rgisSwAVlBnhMgcoasBoyMkbLFkFwKaipoCKFNZcGSMGT21JLXVCEXyGP05JWwFUGjcH4UWKNOj-y7ctNYTj9-sDOOVpRXt5hcevg19C5ZZnG3q3j7EN3S5M0vT7uyd_iB9QZO5E |
| ContentType | Patent |
| CorporateAuthor | University of Houston System |
| CorporateAuthor_xml | – name: University of Houston System |
| DBID | EFI |
| DatabaseName | USPTO Published Applications |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EFI name: USPTO Published Applications url: http://www.uspto.gov/patft/index.html sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| ExternalDocumentID | 20190216756 |
| GroupedDBID | EFI |
| ID | FETCH-uspatents_applications_163660943 |
| IEDL.DBID | EFI |
| IngestDate | Sun Mar 05 22:10:03 EST 2023 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-uspatents_applications_163660943 |
| OpenAccessLink | https://patentcenter.uspto.gov/applications/16366094 |
| ParticipantIDs | uspatents_applications_16366094 |
| PublicationCentury | 2000 |
| PublicationDate | 20190327 |
| PublicationDateYYYYMMDD | 2019-03-27 |
| PublicationDate_xml | – month: 03 year: 2019 text: 20190327 day: 27 |
| PublicationDecade | 2010 |
| PublicationYear | 2019 |
| Score | 3.1187365 |
| Snippet | In an embodiment of the present disclosure, there is provided a composition for dissolving calcium oxalate crystals thereby inhibiting/preventing further... |
| SourceID | uspatents |
| SourceType | Open Access Repository |
| Title | ORGANIC ACIDS AS AGENTS TO DISSOLVE CALCIUM MINERALS IN PATHOLOGICAL CALCIFICATION AND USES THEREOF |
| URI | https://patentcenter.uspto.gov/applications/16366094 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV09b8IwED0VVKnt1Kqt-l0PVbdUBvLFaCUOcUUSRJKKDcXGGSmC8P97caGiE5In62ydPNx7J79nA7xJKb0-QpclfWeIDUpdW9KRtkWr2vGoVnRh_BVJ6sal_TlzZjtTWOuFWSHDWjatMFGvP7abVfNt1JX_bnORQrgutiUd6Phu-14-j8QFnGG0Wbw5AIjoEk4nZvYKTvTyGlQ2HbFUBIQFIswJwzHiaZGTIiOhyPNs_MVJwMaBKBOSCKMey4lIyYQV8f5_gt-AaGf1JSwNSYnVjxQxn_IsuoH3iBdBbP1lND_Mf77Pf3ALXezx9R0Q26V-5SmlFlTblap93RvUtqqQvfXoQMp7eD2y2cPRiEc4R7QftgKqvvcE3Wa91c-IqI18MUf4A_8helg |
| linkProvider | USPTO |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT8MwDLZgIB4nECDeywFxK-q2Psaxaps1sKXV2qLdqiZtTtBNrBN_H7cbaLdJOUWWZTmOH8pnB-BJCGH3MXRpYmi-YoGilCZMYWh6rkxbL6VetP0VE24FqfE2M2eb9ui2F-YLr5G2QFmWL6vlop634Ep07-uD19bDn5sZgVUzfeCn-pznRVQoLOIxtPV7mP9a-3CAVjVo7N2n7BSOkREmblW93Aod9AwOo3b3HPbK6gJkOB05nLnEcZkXEwfXyOdJTJKQeCyOw_GHT1xn7LJ0QiasxZXFhHESOUnw93PBmoBumoCJwz2Sol8kSeBP_ZBewjP1EzfQ_iXKtt-pM0yOLKvB-l1BB6v_8hqIYenD3JZSFnpp5FINy95AGTLHvK6nD4S4ge4OZrc7KbpwFHk0GzP-fgcnjSYblFXfvodO_b0qHzDs1uKx1eYv67mFoA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ORGANIC+ACIDS+AS+AGENTS+TO+DISSOLVE+CALCIUM+MINERALS+IN+PATHOLOGICAL+CALCIFICATION+AND+USES+THEREOF&rft.date=2019-03-27&rft.externalDBID=n%2Fa&rft.externalDocID=20190216756 |